Loncastuximab tesirine as a successful bridge to allogeneic hematopoietic cell transplantation in a heavily pretreated patient with T-cell/histiocyte-rich large B-cell lymphoma
Hematology in Clinical Practice · 13.02.2026 · 17
DOI: 10.5603/hicp.112820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology in Clinical Practice, online erschienen am 13.02.2026. Verfasst von Marcin Jasiński und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jasiński, M., Izdebski, B., Kacprzyk, P., Kobylecka, M., Basak, G., Tomaszewska, A., & Drozd-Sokołowska, J. (2026). Loncastuximab tesirine as a successful bridge to allogeneic hematopoietic cell transplantation in a heavily pretreated patient with T-cell/histiocyte-rich large B-cell lymphoma. Hematology in Clinical Practice, 17(0). https://doi.org/10.5603/hicp.112820
Vancouver
Jasiński M, Izdebski B, Kacprzyk P, Kobylecka M, Basak G, Tomaszewska A, et al. Loncastuximab tesirine as a successful bridge to allogeneic hematopoietic cell transplantation in a heavily pretreated patient with T-cell/histiocyte-rich large B-cell lymphoma. Hematology in Clinical Practice. 2026;17(0). doi:10.5603/hicp.112820
BibTeX
@article{Jasiski2026,
author = {Jasiński, Marcin and Izdebski, Błażej and Kacprzyk, Piotr and Kobylecka, Małgorzata and Basak, Grzegorz and Tomaszewska, Agnieszka and Drozd-Sokołowska, Joanna},
title = {Loncastuximab tesirine as a successful bridge to allogeneic hematopoietic cell transplantation in a heavily pretreated patient with T-cell/histiocyte-rich large B-cell lymphoma},
journal = {Hematology in Clinical Practice},
year = {2026},
volume = {17},
number = {0},
doi = {10.5603/hicp.112820}
}
EUVIMED